These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36367194)

  • 1. Novel Retroperitoneal Neovascularity Scoring System in Renal Cell Carcinoma Tumor Staging.
    Fateri C; Peta A; Limfueco L; Bui TL; Kar N; Glavis-Bloom J; Roth B; Landman J; Houshyar R
    J Endourol; 2023 Mar; 37(3):367-373. PubMed ID: 36367194
    [No Abstract]   [Full Text] [Related]  

  • 2. Neovascularity as a prognostic marker in renal cell carcinoma.
    Bauman TM; Huang W; Lee MH; Abel EJ
    Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Re-VASC, the Novel Retroperitoneal Neovascularity Scoring System, for Characterization of T1a Small Renal Masses.
    Fateri C; Roth B; Rao S; Peta A; Limfueco L; Bui TL; Kar N; Glavis-Bloom J; Cumpanas A; Landman J; Houshyar R
    J Endourol; 2024 Mar; 38(3):301-305. PubMed ID: 38149604
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
    Zhu H; Zhao S; Zuo C; Ren F
    AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
    [No Abstract]   [Full Text] [Related]  

  • 5. Accuracy of multi-detector computed tomography (MDCT) in staging of renal cell carcinoma (RCC): analysis of risk factors for mis-staging and its impact on surgical intervention.
    El-Hefnawy AS; Mosbah A; El-Diasty T; Hassan M; Shaaban AA
    World J Urol; 2013 Aug; 31(4):887-91. PubMed ID: 22200936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Sarcomatoid Renal Cell Carcinoma With CT: Evaluation by Qualitative Imaging Features and Texture Analysis.
    Schieda N; Thornhill RE; Al-Subhi M; McInnes MD; Shabana WM; van der Pol CB; Flood TA
    AJR Am J Roentgenol; 2015 May; 204(5):1013-23. PubMed ID: 25905936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns.
    Tordjman M; Dbjay J; Chamouni A; Morini A; Timsit MO; Mejean A; Vasiliu V; Eiss D; Correas JM; Verkarre V; Helenon O
    AJR Am J Roentgenol; 2020 Mar; 214(3):579-587. PubMed ID: 31770020
    [No Abstract]   [Full Text] [Related]  

  • 8. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
    Wang K; Dong L; Li S; Liu Y; Niu Y; Li G
    BMC Cancer; 2024 Jan; 24(1):148. PubMed ID: 38291357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired cystic disease subtype renal cell carcinoma (ACD-RCC): prevalence and imaging features at a single institution.
    Carnahan MB; Kunzelman J; Kawashima A; Patel BN; Menias CO; Fananapazir G
    Abdom Radiol (NY); 2022 Aug; 47(8):2858-2866. PubMed ID: 35674787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative staging of renal cell carcinoma with multidetector CT.
    Türkvatan A; Akdur PO; Altinel M; Olçer T; Turhan N; Cumhur T; Akinci S; Ozkul F
    Diagn Interv Radiol; 2009 Mar; 15(1):22-30. PubMed ID: 19263370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
    Hou G; Zhao D; Jiang Y; Zhu Z; Huo L; Li F; Cheng W
    Cancer Imaging; 2021 Feb; 21(1):25. PubMed ID: 33632314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney morcellation in laparoscopic nephrectomy for tumor: recommendations for specimen sampling and pathologic tumor staging.
    Rabban JT; Meng MV; Yeh B; Koppie T; Ferrell L; Stoller ML
    Am J Surg Pathol; 2001 Sep; 25(9):1158-66. PubMed ID: 11688575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT of renal cell carcinoma: assessment of collecting system invasion.
    Karlo CA; Di Paolo PL; Hricak H; Tickoo SK; Russo P; Akin O
    AJR Am J Roentgenol; 2013 Dec; 201(6):W821-7. PubMed ID: 24261389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of modern combined methods in diagnosis of renal cell carcinoma].
    Teodorovich OV; Ternovoĭ SK; Vlasova IS; Zabrodina NB; Fominykh EV; Kesov IaE
    Urologiia; 2006; (5):3-6, 11. PubMed ID: 17444144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.
    Honda Y; Goto K; Nakamura Y; Terada H; Sentani K; Yasui W; Sekino Y; Hayashi T; Teishima J; Matsubara A; Fuji T; Kaichi Y; Higaki T; Baba Y; Iida M; Awai K
    Abdom Radiol (NY); 2017 Jul; 42(7):1850-1856. PubMed ID: 28534069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
    Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
    World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.